Latham & Watkins Advises KKR & Co. on Investment in Cotiviti

Cotiviti, a leading healthcare data and technology business, has announced that it has entered into a definitive agreement to recapitalize the business. Under the agreement, KKR will acquire an equal ownership interest in Cotiviti with affiliates of Veritas Capital, Cotiviti’s current private equity partner. The transaction is expected to close in the second quarter of 2024, subject to customary closing conditions, including regulatory approvals.

Latham & Watkins LLP represents KKR in key healthcare regulatory, insurance regulatory, and HIPAA aspects of the transaction, with a team led by Washington, D.C. partners Jason Caron and Joseph Hudzik, and Bay Area partner Betty Pang, with associates Megan Lich, and Yanyan Zhou. Advice was also provided on insurance regulatory matters by New York counsel Benjamin Lee; on health regulatory matters by Los Angeles associate Amanda Barnett; and on HIPAA matters by Bay Area partner Heather Deixler, with associate Mitch Bennett.*  

*Admitted to practice in New South Wales, Australia only.